机译:Lu-177-PSMA-617在转移阉割前列腺癌中的剂量测定方法:使用治疗结果的普拉克测性成像与全身肿瘤剂量术之间的相关性
Peter MacCallum Canc Ctr Dept Radiat Oncol Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Radiat Oncol Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Med Oncol Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Urooncol Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Radiat Oncol Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Peter MacCallum Canc Ctr Dept Mol Imaging Melbourne Vic Australia;
Lu-177-PSMA-617; dosimetry; prostate cancer; theranostics; radionuclide therapy;
机译:Lu-177-PSMA-617在转移阉割前列腺癌中的剂量测定方法:使用治疗结果的普拉克测性成像与全身肿瘤剂量术之间的相关性
机译:177Lu-PSMA I&T在转移性去势抵抗性前列腺癌中的放射剂量测定:正常器官和肿瘤病变的吸收剂量
机译:转移阉割抗阉割前列腺癌中Lu-177-PSMA I&T的辐射剂量测定:正常器官和肿瘤病变中的吸收剂量
机译:转移激素敏感和阉割的前列腺癌:进步和持续发现的十年
机译:基于转录的分子模型和基因治疗转化模型中去势抵抗和转移性前列腺癌的研究
机译:177Lu-PSMA-617治疗转移性去势抵抗性前列腺癌的剂量学反应和患者报告结局的初步经验
机译:177LU-PSMA I&T在转移性阉割前列腺癌中的辐射剂量测定剂:正常器官和肿瘤病变中的吸收剂量